Kayla A. Schardien - Publications

Affiliations: 
2018-2020 National Institutes of Health, Bethesda, MD 

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sánchez-Soto M, Boldizsar NM, Schardien KA, Madaras NS, Willette BKA, Inbody LR, Dasaro C, Moritz AE, Drube J, Haider RS, Free RB, Hoffman C, Sibley DR. G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation. Biomolecules. 13. PMID 37892234 DOI: 10.3390/biom13101552  0.564
2020 Schardien KA, Soto MS, Inbody L, Berchiche Y, Kehrl JH, Bradfield C, Free RB, Sibley DR. Investigation of G protein‐coupled receptor kinase 2 (GRK2) regulation of D 2 dopamine receptor signaling: effects of GRK2 functional domains and pharmacologic and genetic inhibition of GRK2 activity The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05825  0.538
2020 Sanchez-Soto M, Schardien KA, Inbody L, Free RB, Sibley DR. G protein‐coupled receptor kinase 2 can enhance beta‐arrestin recruitment to the D 2 dopamine receptor in the absence of receptor phosphorylation The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03478  0.552
Show low-probability matches.